GlassScriptPhysician profile
Mariann Alperin
NPI 1033266879
$17,696.69
in general payments reported to CMS, 2019-2025
9 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,300 · 2020: $37.67 · 2021: $4,980 · 2022: $64.48 · 2023: $8,994 · 2024: $104 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Travel and Lodging: $1,326 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Travel and Lodging | $1,326.33 |
| Food and Beverage | $488.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,869.77 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Renovia INC | $8,250.00 | 2019-2021 | |
| Abbvie INC. | $196.79 | 2024-2025 | |
| Coloplast Corp | $99.62 | 2022-2023 | Saffron |
| Medtronic, INC. | $68.80 | 2025 | Altaviva |
| Baxter Healthcare | $63.83 | 2023 | Tisseel |
| Boston Scientific Corporation | $60.69 | 2020-2025 | Bulkamid |
| Axonics, INC. | $57.46 | 2023-2024 | Axonics |
| Urovant Sciences INC | $29.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariann Alperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.